3644 results for «2817»
3644 results
Aortic valve-in-valve or TAV-in-TAV challenges
15 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the challenges of aortic valve-in-valve or TAV-in-TAV procedures. The session will feature various complex cases, including when even two surgeries are not enough, resilient rhythms in geriatric resurgence, valve-in-valve TAVI for degenerated small surgical bioprosthetic...
Fistula aneurysms
14 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the management of fistula aneurysms. The cases cover a range of scenarios, including a rare cause of right ventricular compression, a giant coronary fistula, suspected coronary steal syndrome, and more. Each case is followed by...
Calcified coronary lesions: procedural techniques
15 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Clinical Case submissions, focuses on procedural techniques for the management of calcified coronary lesions. It will feature various complex cases, including in-stent shave and debulk, damned coronary nodules, rotatripsy burring before the shock, protected high-risk PCI of a heavily calcified...
Complications in STEMI: sharing is key
15 May 2024 – From EuroPCR 2024
This session covers challenging STEMI complications, including stent dislodgement, anterior STEMI without PCI, LIMA occlusion from iatrogenic dissection, and AMI complicated by left main occlusion. Gain insights on managing these cases and the importance of collaboration in finding optimal solutions.
Second generation biolimus drug-coated balloon in clinical practice
15 May 2024 – From EuroPCR 2024
Discover the potential applications of the new biolimus-coated balloon in treating de novo large vessel lesions, explore its effectiveness in addressing ISR based on findings from the BIO ASCEND ISR study, and uncover insights into the safety and feasibility of BA9 DCB in treating small vessel,...
The future of interventional cardiology imaging
15 May 2024 – From EuroPCR 2024
Explore this session to discover the latest innovations in interventional cardiology images, including the benefits of artificial intelligence and angio-CT in PCI/SHD procedures. Learn about Alphenix Evolve and the initial experiences with AI imaging in daily cathlab practice, alongside intraprocedural angio-CT guided LAAO, and engage in...
Post PCI anti-thrombotic strategies
15 May 2024 – From EuroPCR 2024
PCI: from basics to robots
14 May 2024 – From EuroPCR 2024
This session covers a wide range of topics in percutaneous coronary intervention (PCI), from fundamental aspects to the latest advancements. It includes discussions on non-fasting versus fasting before interventional procedures, radial artery puncture hemostasis, ultrasound-guided transfemoral puncture in complex PCI, the use of uninterrupted direct-acting oral...
Clinical adoption of renal denervation: no more excuses
15 May 2024 – From EuroPCR 2024
PCI: complex procedures
14 May 2024 – From EuroPCR 2024
This session explores a series of complex PCI cases, including the management of left main stent restenosis after the chimney technique, aortic root dissection during right coronary artery PCI, treatment of very old saphenous graft disease, complex in-stent restenosis, and the management of persistent coronary fistula....
INOCA/ANOCA: view insights from clinical practice
19 May 2026 – From EuroPCR 2026
This session provides in-depth clinical insights into INOCA and ANOCA by exploring innovative invasive assessments of coronary microcirculation and vasoreactivity, with a focus on diabetic populations and sex differences. It reviews distinct IMR-based phenotypes differentiating flow versus pressure-driven microvascular dysfunction, and the role of invasive hemodynamics...
News from drug-eluting therapies in 2026
19 May 2026 – From EuroPCR 2026
This session presents the latest advancements in drug-eluting therapies for 2026, including predictors of target lesion failure after drug-coated balloon treatment, clinical outcomes related to stenting length, and novel insights into sirolimus transfer evidenced by in vivo OCT imaging.
Radial and distal radial artery access for PCI
19 May 2026 – From EuroPCR 2026
This session provides an in-depth evaluation of radial and distal radial artery access for PCI, including a 20-year trend analysis of clinical outcomes, feasibility studies on distal radial interventions, and comparative real-world experiences. It also features meta-analyses of randomized trials on access approaches and early findings...
Treatment for calcified coronary artery disease in the real world
19 May 2026 – From EuroPCR 2026
This session presents real-world experiences and evidence on treating calcified coronary artery disease. It includes meta-analyses comparing rotational atherectomy and balloon angioplasty, long-term outcomes of excimer laser atherectomy, and multicenter registry data on intravascular lithotripsy (IVL), particularly in diabetic and high-risk patients. The session also focuses...
TAVI complications: impact and improvement
20 May 2026 – From EuroPCR 2026
This session examines critical complications associated with TAVI and strategies to mitigate their impact. Topics include carbon-dioxide flushing to reduce brain injury, management of cardiac tamponade, AI-driven customization of TAVI in complex anatomies, and the influence of vascular complications on post-procedural quality of life.
INOCA/ANOCA: technical aspects
20 May 2026 – From EuroPCR 2026
This session covers technical aspects critical to the evaluation and management of ischemia with non-obstructive coronary arteries (INOCA) and angina with non-obstructive coronary arteries (ANOCA). Key topics include the impact of guide catheter shape, injection techniques for thermodilution measurements, advanced perfusion CMR diagnostics, and the physiological...
FFR and non-hyperaemic pressure ratios
20 May 2026 – From EuroPCR 2026
This session presents contemporary clinical applications of fractional flow reserve (FFR) and non-hyperaemic pressure ratios (NHPR), highlighting real-world impacts of physiology microcatheter-based indices, the interplay between epicardial stenosis and microvascular resistance, post-PCI hyperemia effects on iFR, and machine-learning driven outcome predictions.
Other right-sided and tricuspid valve interventions
20 May 2026 – From EuroPCR 2026
This session focuses on right-sided heart valve interventions, particularly targeting tricuspid valve disease. Topics include clinical outcomes in atrial functional tricuspid regurgitation, management in the context of left-sided valvular disease, treatment approaches for tricuspid valve endocarditis, and advances in transcatheter therapies and device placements.
Insights from real world TAVI practice
20 May 2026 – From EuroPCR 2026
This session presents comprehensive insights from real-world transcatheter aortic valve implantation (TAVI) practice, including sex differences in coronary assessment, the impact of general anesthesia on aortic valve gradients, early rehospitalisation rates, and the management of TAVI in patients with prior hip arthroplasty. Additionally, it explores multinational...
Continual refinement in LAA closure
20 May 2026 – From EuroPCR 2026
This session presents the latest advancements in left atrial appendage closure (LAAC). It covers new risk scoring systems, sex-specific outcome analyses, safety in elderly populations, and comparative data between LAMBRE and WATCHMAN devices from a high-volume center, highlighting continual refinement in LAAC strategies.